BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9122243)

  • 1. Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes.
    Ikushima S; Inukai T; Inaba T; Nimer SD; Cleveland JL; Look AT
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2609-14. PubMed ID: 9122243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
    Yeung J; O'Sullivan E; Hubank M; Brady HJ
    Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
    Inukai T; Inaba T; Ikushima S; Look AT
    Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
    Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
    Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
    Dang J; Inukai T; Kurosawa H; Goi K; Inaba T; Lenny NT; Downing JR; Stifani S; Look AT
    Mol Cell Biol; 2001 Sep; 21(17):5935-45. PubMed ID: 11486032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors.
    Inukai T; Inaba T; Dang J; Kuribara R; Ozawa K; Miyajima A; Wu W; Look AT; Arinobu Y; Iwasaki H; Akashi K; Kagami K; Goi K; Sugita K; Nakazawa S
    Blood; 2005 Jun; 105(11):4437-44. PubMed ID: 15665112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
    Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
    Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.
    Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H
    Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
    Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
    Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell transformation mediated by homodimeric E2A-HLF transcription factors.
    Inukai T; Inaba T; Yoshihara T; Look AT
    Mol Cell Biol; 1997 Mar; 17(3):1417-24. PubMed ID: 9032268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
    Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.
    Chen W; Yu YL; Lee SF; Chiang YJ; Chao JR; Huang JH; Chiong JH; Huang CJ; Lai MZ; Yang-Yen HF; Yen JJ
    Mol Cell Biol; 2001 Jul; 21(14):4636-46. PubMed ID: 11416141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF.
    Yoshihara T; Inaba T; Shapiro LH; Kato JY; Look AT
    Mol Cell Biol; 1995 Jun; 15(6):3247-55. PubMed ID: 7760820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct interleukin-3-mediated signal pathways, Ras-NFIL3 (E4BP4) and Bcl-xL, regulate the survival of murine pro-B lymphocytes.
    Kuribara R; Kinoshita T; Miyajima A; Shinjyo T; Yoshihara T; Inukai T; Ozawa K; Look AT; Inaba T
    Mol Cell Biol; 1999 Apr; 19(4):2754-62. PubMed ID: 10082541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein.
    Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT
    Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
    Hunger SP; Brown R; Cleary ML
    Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA factors are essential for transcription of the survival gene E4bp4 and the viability response of interleukin-3 in Ba/F3 hematopoietic cells.
    Yu YL; Chiang YJ; Yen JJ
    J Biol Chem; 2002 Jul; 277(30):27144-53. PubMed ID: 12023274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone-induced E4BP4/NFIL3 down-regulates transcription in osteoblasts.
    Ozkurt IC; Tetradis S
    J Biol Chem; 2003 Jul; 278(29):26803-9. PubMed ID: 12743120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.
    Smith KS; Rhee JW; Cleary ML
    Mol Cell Biol; 2002 Nov; 22(21):7678-87. PubMed ID: 12370314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-dependent activation of nuclear factor regulated by interleukin 3/adenovirus E4 promoter-binding protein gene expression by calcineurin/nuclear factor of activated T cells and calcium/calmodulin-dependent protein kinase signaling.
    Nishimura Y; Tanaka T
    J Biol Chem; 2001 Jun; 276(23):19921-8. PubMed ID: 11262393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.